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Background:  Efforts to achieve durable survival in hypoplastic left heart syndrome (HLHS) through staged surgical palliation require 
sophisticated inpatient (inpt) care and are not always successful. Our purpose is to measure the investment of inpt care resources in this 
effort and determine how much of that investment takes place in hospitalizations that have a fatal outcome.
methods:  The Pediatric Health Information System (PHIS) database representing 47 children’s hospitals was queried for HLHS 
admissions of patients (pts) <21 years old during 2004-2013. Institution, pt age, inpt deaths, billed charges (BC) and length of stay (LOS) 
were recorded.
results:  In total, 11,122 HLHS admissions (mean 259±181 per institution) were identified which account for total LOS of 277,027 inpt-days 
and $3,928,794,660 in BC. There were 1145 inpt deaths (10.3%). Mean, interquartile range, and median were: for pt age 1.13, 0-2, and 0 
years, for LOS 24.9, 6-29, and 12 days, and for BC 353,000 86,000-392,000, and 175,000 ($). LOS was greater among inpt deaths than 
among pts discharged alive (median 17 vs 12, p<0.0001). BC were greater among inpt deaths than among pts discharged alive (median 
4.09x105 vs 1.64x105, p<0.0001). 16% of all LOS and 21% of all BC were accrued by pts who did not survive their hospitalization. These 
proportions show no significant change year by year.
Conclusion:  Investment of resources in inpt care of HLHS is high, disproportionately so among pts who do not survive their 
hospitalization, illustrating that inpt death in HLHS generally is neither swift nor inexpensive. Inpt death is a crude outcome marker, and 
may substantially underestimate the larger problem of investment in more general poor outcomes in HLHS manifested as early post-
dismissal deaths and severe nonfatal morbidities. Nevertheless, these sobering data should alert providers and consumers that current 
practices often result in major resource expenditure for inpt care of HLHS which prove unsuccessful even in the short term. They highlight 
the need for data-driven critical review of standard practices to identify patterns of care associated with success in HLHS, and to modify 
approaches objectively.
